Phase 1 Trial Records NeoVax Vaccine as Feasible and Acceptably SafeBy Ciara SullivanOctober 16, 20260 A phase 1 trial in Nature Medicine records a personalised neoantigen vaccine with nivolumab as feasible and acceptably safe in platinum-sensitive ovarian cancer.
